Femasys inc. to showcase femaseed at the annual meeting of the american society of reproductive medicine

Atlanta, oct. 04, 2023 (globe newswire) -- femasys inc. (nasdaq: femy), a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it will be exhibiting at the annual meeting of the american society of reproductive medicine (asrm): “the past, the present, and the pipeline”, being held in new orleans, louisiana from october 14-18, 2023.
FEMY Ratings Summary
FEMY Quant Ranking